In contrast, lovastatin treatment alone inhibited AKT, S6K1 and 4EPB1 phosphorylation and the combination of lovastatin and KRN633 induced a dramatic inhibition of the AKT pathway in this MM derived cell line (Figure 5). The gene discussed is RPS6KB1; the disease is Miyoshi myopathy.